Resolvin D1 Reduces Lung Infection and Inflammation Activating Resolution in Cystic Fibrosis
Non-resolving lung inflammation and Pseudomonas aeruginosa infections are the underlying cause of morbidity and mortality in cystic fibrosis (CF). The endogenous lipid mediator resolvin (Rv) D1 is a potent regulator of resolution, and its roles, actions, and therapeutic potential in CF are of intere...
Main Authors: | Elisa Isopi, Domenico Mattoscio, Marilina Codagnone, Veronica Cecilia Mari, Alessia Lamolinara, Sara Patruno, Marco D’Aurora, Eleonora Cianci, Annalisa Nespoli, Sara Franchi, Valentina Gatta, Marc Dubourdeau, Paolo Moretti, Maria Di Sabatino, Manuela Iezzi, Mario Romano, Antonio Recchiuti |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-04-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2020.00581/full |
Similar Items
-
Resolvin D1 reduces cancer growth stimulating a protective neutrophil-dependent recruitment of anti-tumor monocytes
by: Domenico Mattoscio, et al.
Published: (2021-04-01) -
Roles of Specialized Pro-Resolving Lipid Mediators in Autophagy and Inflammation
by: Antonio Recchiuti, et al.
Published: (2020-09-01) -
Gene Expression of the D-Series Resolvin Pathway Predicts Activation of Anti-Tumor Immunity and Clinical Outcomes in Head and Neck Cancer
by: Domenico Mattoscio, et al.
Published: (2022-06-01) -
Aspirin-Triggered Resolvin D1 Reduces Chronic Dust-Induced Lung Pathology without Altering Susceptibility to Dust-Enhanced Carcinogenesis
by: Edward C. Dominguez, et al.
Published: (2022-04-01) -
Roles, Actions, and Therapeutic Potential of Specialized Pro-resolving Lipid Mediators for the Treatment of Inflammation in Cystic Fibrosis
by: Antonio Recchiuti, et al.
Published: (2019-04-01)